Back to User profile » Mr Thomas Bengtsson

Papers published by Mr Thomas Bengtsson:

Review

Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD

Donohue JF, Rheault T, MacDonald-Berko M, Bengtsson T, Rickard K

International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1611-1622

Published Date: 28 July 2023

Original Research

A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy

Ferguson GT, Kerwin EM, Rheault T, Bengtsson T, Rickard K

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1137-1148

Published Date: 22 April 2021

Original Research

Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD – A Detailed Analysis

Watz H, Rickard K, Rheault T, Bengtsson T, Singh D

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2199-2206

Published Date: 16 September 2020

Original Research

Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA)

Bjermer L, Kuna P, Jorup C, Bengtsson T, Rosenborg J

Drug Design, Development and Therapy 2015, 9:753-762

Published Date: 5 February 2015